Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guigao Lin

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
Intervirology|January 20, 2016
Is Anti-Hepatitis C Virus Antibody Level an Appropriate Marker to Preclude the Need for Supplemental TestingKuo Zhang, Lunan Wang, Guigao Lin, et al.
Frontiers in Oncology|May 16, 2022
Development of a Novel Reference Material for Tumor Mutational Burden Measurement Based on CRISPR/Cas9 TechnologyRongxue Peng, Guigao Lin, Lin Li, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 19, 2022
A multi-laboratory assessment of clinical exome sequencing for detection of hereditary disease variants: 4441 ClinVar variants for clinical genomic test development and validationKuo Zhang, Lijia Yu, Guigao Lin, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 30, 2016
Serological diagnosis of toxoplasmosis and standardizationKuo Zhang, Guigao Lin, Yanxi Han, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 12, 2017
The standardization of 5 immunoassays for anti-Toxoplasma immunoglobulin G(IgG)Kuo Zhang, Guigao Lin, Yanxi Han, et al.
Clinical Chemistry and Laboratory Medicine|November 16, 2016
Quality control materials for pharmacogenomic testing in the clinicGuigao Lin, Kuo Zhang, Yanxi Han, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 19, 2018
Current progress of tacrolimus dosing in solid organ transplant recipients: Pharmacogenetic considerationsXiao Zhang, Guigao Lin, Liming Tan, et al.
Journal of Medical Virology|January 5, 2024
CRISPR-Cas system: A promising tool for rapid detection of SARS-CoV-2 variantsJing Li, Kuo Zhang, Guigao Lin, et al.
Clinical Epigenetics|April 29, 2017
Circulating unmethylated insulin DNA as a potential non-invasive biomarker of beta cell death in type 1 Diabetes: a review and future prospectKuo Zhang, Guigao Lin, Yanxi Han, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 21, 2019
Molecular genetic testing and diagnosis strategies for dystrophinopathies in the era of next generation sequencingKuo Zhang, Xin Yang, Guigao Lin, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Intervirology|January 20, 2016
Is Anti-Hepatitis C Virus Antibody Level an Appropriate Marker to Preclude the Need for Supplemental TestingKuo Zhang, Lunan Wang, Guigao Lin, et al.
Frontiers in Oncology|May 16, 2022
Development of a Novel Reference Material for Tumor Mutational Burden Measurement Based on CRISPR/Cas9 TechnologyRongxue Peng, Guigao Lin, Lin Li, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 19, 2022
A multi-laboratory assessment of clinical exome sequencing for detection of hereditary disease variants: 4441 ClinVar variants for clinical genomic test development and validationKuo Zhang, Lijia Yu, Guigao Lin, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 30, 2016
Serological diagnosis of toxoplasmosis and standardizationKuo Zhang, Guigao Lin, Yanxi Han, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 12, 2017
The standardization of 5 immunoassays for anti-Toxoplasma immunoglobulin G(IgG)Kuo Zhang, Guigao Lin, Yanxi Han, et al.
Clinical Chemistry and Laboratory Medicine|November 16, 2016
Quality control materials for pharmacogenomic testing in the clinicGuigao Lin, Kuo Zhang, Yanxi Han, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 19, 2018
Current progress of tacrolimus dosing in solid organ transplant recipients: Pharmacogenetic considerationsXiao Zhang, Guigao Lin, Liming Tan, et al.
Journal of Medical Virology|January 5, 2024
CRISPR-Cas system: A promising tool for rapid detection of SARS-CoV-2 variantsJing Li, Kuo Zhang, Guigao Lin, et al.
Clinical Epigenetics|April 29, 2017
Circulating unmethylated insulin DNA as a potential non-invasive biomarker of beta cell death in type 1 Diabetes: a review and future prospectKuo Zhang, Guigao Lin, Yanxi Han, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 21, 2019
Molecular genetic testing and diagnosis strategies for dystrophinopathies in the era of next generation sequencingKuo Zhang, Xin Yang, Guigao Lin, et al.
Pageof 7